Skip to main content
Joanne Billings, MD, Pulmonology, Minneapolis, MN, M Health Fairview University of Minnesota Medical Center

JoanneLauretteBillingsMD

Pulmonology Minneapolis, MN

Critical Care Medicine, Pleural Disease

Associate Professor, Medicine, University of Minnesota Medical School

Dr. Billings is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Billings' full profile

Already have an account?

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 2000
  • University of Minnesota
    University of MinnesotaResidency, Internal Medicine, 1992 - 1995
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1992

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1994 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19  
    Victor Tapson, Daniel A Sweeney, Richard A Mularski, Alpesh N Amin, Joanne Billings, Marie-Carmelle Elie, The New England Journal of Medicine

Grant Support

  • Multidose Safety And Tolerability Study Of Liposomal Amikacin For Inhalation (ArNational Center For Research Resources2009
  • Kb001-03: A Phase I/II Randomized, Double-Blind, Placebo-Controlled, Single-DoseNational Center For Research Resources2009
  • Expanded Access Program For Aztreonamn Lysine For Inhalation In Patients With CYNational Center For Research Resources2009
  • Inhaled Sodium Pyruvate For The Treatment Of Cystic Fibrosis A Phase I, DoubleNational Center For Research Resources2008
  • A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial WithNational Center For Research Resources2008
  • Women'S Health In Cystic FibrosisNational Center For Research Resources2004–2007
  • A Phase II, Randomized, Double Blind, Parallel Dose Study Of Oral Theraclec-TotaNational Center For Research Resources2005–2006
  • Women'S Health In Cystic FibrosisNational Heart, Lung, And Blood Institute2001–2005

Hospital Affiliations